Home › NCT07017972
Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model
Multicenter Data Collection and Simulated-Use Assessment for CHLOE
Who can join
Ages 18 and older · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: 1. Images and data of eggs or embryos available from egg retrievals by women undergoing standard egg-freezing or In vitro fertilization (IVF) treatments, using their own eggs or donor eggs. 2. Women at least 18 years of age. 3. Embryos or eggs cultured in a time-lapse incubator connected to the AI Embryo Viewer. Exclusion Criteria: * Women with no available own or donor eggs.
About the study
This protocol supports the reliable development and improvement of Artificial Intelligence (AI)-based applications by enabling training, verification, and validation using high-quality real clinical data. It also aims to enhance machine learning in developmental-use AI software.
In addition, the professional user simulated use will ensure correct and easy use of the AI applications.
What is being tested
- AI evaluation of embryos (device)
Sponsor: Fairtility · Participants: 4,000 · Started: Jun 20, 2025
Contact the study team
- Pedro Pini, M.D · Phone: +541144704026
Official record on ClinicalTrials.gov — NCT07017972
Locations in the U.S.
| Connecticut | New England Fertility Institute, Stamford |
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.